0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Decentralized & Digitalized Clinical Trials Market Research Report 2026
Published Date: 2026-01-19
|
Report Code: QYRE-Auto-9S18797
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Decentralized Digitalized Clinical Trials Market Research Report 2024
BUY CHAPTERS

Global Decentralized & Digitalized Clinical Trials Market Research Report 2026

Code: QYRE-Auto-9S18797
Report
2026-01-19
Pages:143
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Decentralized & Digitalized Clinical Trials Market Size

The global Decentralized & Digitalized Clinical Trials market was valued at US$ 10060 million in 2025 and is anticipated to reach US$ 21210 million by 2032, at a CAGR of 11.4% from 2026 to 2032.

Decentralized & Digitalized Clinical Trials Market

Decentralized & Digitalized Clinical Trials Market

Decentralized & Digitalized Clinical Trials are an innovative approach to conducting clinical research. They aim to move away from the traditional model that requires participants to visit a central research site (such as a hospital or a dedicated research facility) for most of the trial - related activities. Instead, DCTs bring various aspects of the trial to the participants' local environment, such as their homes or local healthcare centers.
The North American market for Decentralized & Digitalized Clinical Trials is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Decentralized & Digitalized Clinical Trials is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for Decentralized & Digitalized Clinical Trials in Oncology is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of Decentralized & Digitalized Clinical Trials include Medidata, IQVIA, Labcorp, PRA Health Sciences, Parexel, ICON, Oracle, Medpace, Patheon, Signant Health, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Decentralized & Digitalized Clinical Trials market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Decentralized & Digitalized Clinical Trials. The Decentralized & Digitalized Clinical Trials market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Decentralized & Digitalized Clinical Trials market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Decentralized & Digitalized Clinical Trials manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Decentralized & Digitalized Clinical Trials Market Report

Report Metric Details
Report Name Decentralized & Digitalized Clinical Trials Market
Accounted market size in 2025 US$ 10060 million
Forecasted market size in 2032 US$ 21210 million
CAGR 11.4%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Web-based
  • Cloud-based
Segment by Application
  • Oncology
  • Cardiovascular
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Medidata, IQVIA, Labcorp, PRA Health Sciences, Parexel, ICON, Oracle, Medpace, Patheon, Signant Health, Syneos Health, CRF Health, Clinical Ink, Medable, Obvio Health, Fortrea, ProPharma, Cloudbyz, Science 37, Advarra, Medrio, Tigermed, Zhejiang Taimei Medical Technology, Shanghai Yaocheng Health Technology
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for Decentralized & Digitalized Clinical Trials companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Decentralized & Digitalized Clinical Trials Market growing?

Ans: The Decentralized & Digitalized Clinical Trials Market witnessing a CAGR of 11.4% during the forecast period 2026-2032.

What is the Decentralized & Digitalized Clinical Trials Market size in 2032?

Ans: The Decentralized & Digitalized Clinical Trials Market size in 2032 will be US$ 21210 million.

Who are the main players in the Decentralized & Digitalized Clinical Trials Market report?

Ans: The main players in the Decentralized & Digitalized Clinical Trials Market are Medidata, IQVIA, Labcorp, PRA Health Sciences, Parexel, ICON, Oracle, Medpace, Patheon, Signant Health, Syneos Health, CRF Health, Clinical Ink, Medable, Obvio Health, Fortrea, ProPharma, Cloudbyz, Science 37, Advarra, Medrio, Tigermed, Zhejiang Taimei Medical Technology, Shanghai Yaocheng Health Technology

What are the Application segmentation covered in the Decentralized & Digitalized Clinical Trials Market report?

Ans: The Applications covered in the Decentralized & Digitalized Clinical Trials Market report are Oncology, Cardiovascular, Others

What are the Type segmentation covered in the Decentralized & Digitalized Clinical Trials Market report?

Ans: The Types covered in the Decentralized & Digitalized Clinical Trials Market report are Web-based, Cloud-based

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Decentralized & Digitalized Clinical Trials Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Web-based
1.2.3 Cloud-based
1.3 Market by Application
1.3.1 Global Decentralized & Digitalized Clinical Trials Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Oncology
1.3.3 Cardiovascular
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Decentralized & Digitalized Clinical Trials Market Perspective (2021–2032)
2.2 Global Decentralized & Digitalized Clinical Trials Growth Trends by Region
2.2.1 Global Decentralized & Digitalized Clinical Trials Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Decentralized & Digitalized Clinical Trials Historic Market Size by Region (2021–2026)
2.2.3 Decentralized & Digitalized Clinical Trials Forecasted Market Size by Region (2027–2032)
2.3 Decentralized & Digitalized Clinical Trials Market Dynamics
2.3.1 Decentralized & Digitalized Clinical Trials Industry Trends
2.3.2 Decentralized & Digitalized Clinical Trials Market Drivers
2.3.3 Decentralized & Digitalized Clinical Trials Market Challenges
2.3.4 Decentralized & Digitalized Clinical Trials Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Decentralized & Digitalized Clinical Trials Players by Revenue
3.1.1 Global Top Decentralized & Digitalized Clinical Trials Players by Revenue (2021–2026)
3.1.2 Global Decentralized & Digitalized Clinical Trials Revenue Market Share by Players (2021–2026)
3.2 Global Top Decentralized & Digitalized Clinical Trials Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Decentralized & Digitalized Clinical Trials Revenue
3.4 Global Decentralized & Digitalized Clinical Trials Market Concentration Ratio
3.4.1 Global Decentralized & Digitalized Clinical Trials Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Decentralized & Digitalized Clinical Trials Revenue in 2025
3.5 Global Key Players of Decentralized & Digitalized Clinical Trials Head Offices and Areas Served
3.6 Global Key Players of Decentralized & Digitalized Clinical Trials, Products and Applications
3.7 Global Key Players of Decentralized & Digitalized Clinical Trials, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Decentralized & Digitalized Clinical Trials Breakdown Data by Type
4.1 Global Decentralized & Digitalized Clinical Trials Historic Market Size by Type (2021–2026)
4.2 Global Decentralized & Digitalized Clinical Trials Forecasted Market Size by Type (2027–2032)
5 Decentralized & Digitalized Clinical Trials Breakdown Data by Application
5.1 Global Decentralized & Digitalized Clinical Trials Historic Market Size by Application (2021–2026)
5.2 Global Decentralized & Digitalized Clinical Trials Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Decentralized & Digitalized Clinical Trials Market Size (2021–2032)
6.2 North America Decentralized & Digitalized Clinical Trials Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Decentralized & Digitalized Clinical Trials Market Size by Country (2021–2026)
6.4 North America Decentralized & Digitalized Clinical Trials Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Decentralized & Digitalized Clinical Trials Market Size (2021–2032)
7.2 Europe Decentralized & Digitalized Clinical Trials Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Decentralized & Digitalized Clinical Trials Market Size by Country (2021–2026)
7.4 Europe Decentralized & Digitalized Clinical Trials Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Decentralized & Digitalized Clinical Trials Market Size (2021–2032)
8.2 Asia-Pacific Decentralized & Digitalized Clinical Trials Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Decentralized & Digitalized Clinical Trials Market Size by Region (2021–2026)
8.4 Asia-Pacific Decentralized & Digitalized Clinical Trials Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Decentralized & Digitalized Clinical Trials Market Size (2021–2032)
9.2 Latin America Decentralized & Digitalized Clinical Trials Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Decentralized & Digitalized Clinical Trials Market Size by Country (2021–2026)
9.4 Latin America Decentralized & Digitalized Clinical Trials Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Decentralized & Digitalized Clinical Trials Market Size (2021–2032)
10.2 Middle East & Africa Decentralized & Digitalized Clinical Trials Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Decentralized & Digitalized Clinical Trials Market Size by Country (2021–2026)
10.4 Middle East & Africa Decentralized & Digitalized Clinical Trials Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Medidata
11.1.1 Medidata Company Details
11.1.2 Medidata Business Overview
11.1.3 Medidata Decentralized & Digitalized Clinical Trials Introduction
11.1.4 Medidata Revenue in Decentralized & Digitalized Clinical Trials Business (2021–2026)
11.1.5 Medidata Recent Development
11.2 IQVIA
11.2.1 IQVIA Company Details
11.2.2 IQVIA Business Overview
11.2.3 IQVIA Decentralized & Digitalized Clinical Trials Introduction
11.2.4 IQVIA Revenue in Decentralized & Digitalized Clinical Trials Business (2021–2026)
11.2.5 IQVIA Recent Development
11.3 Labcorp
11.3.1 Labcorp Company Details
11.3.2 Labcorp Business Overview
11.3.3 Labcorp Decentralized & Digitalized Clinical Trials Introduction
11.3.4 Labcorp Revenue in Decentralized & Digitalized Clinical Trials Business (2021–2026)
11.3.5 Labcorp Recent Development
11.4 PRA Health Sciences
11.4.1 PRA Health Sciences Company Details
11.4.2 PRA Health Sciences Business Overview
11.4.3 PRA Health Sciences Decentralized & Digitalized Clinical Trials Introduction
11.4.4 PRA Health Sciences Revenue in Decentralized & Digitalized Clinical Trials Business (2021–2026)
11.4.5 PRA Health Sciences Recent Development
11.5 Parexel
11.5.1 Parexel Company Details
11.5.2 Parexel Business Overview
11.5.3 Parexel Decentralized & Digitalized Clinical Trials Introduction
11.5.4 Parexel Revenue in Decentralized & Digitalized Clinical Trials Business (2021–2026)
11.5.5 Parexel Recent Development
11.6 ICON
11.6.1 ICON Company Details
11.6.2 ICON Business Overview
11.6.3 ICON Decentralized & Digitalized Clinical Trials Introduction
11.6.4 ICON Revenue in Decentralized & Digitalized Clinical Trials Business (2021–2026)
11.6.5 ICON Recent Development
11.7 Oracle
11.7.1 Oracle Company Details
11.7.2 Oracle Business Overview
11.7.3 Oracle Decentralized & Digitalized Clinical Trials Introduction
11.7.4 Oracle Revenue in Decentralized & Digitalized Clinical Trials Business (2021–2026)
11.7.5 Oracle Recent Development
11.8 Medpace
11.8.1 Medpace Company Details
11.8.2 Medpace Business Overview
11.8.3 Medpace Decentralized & Digitalized Clinical Trials Introduction
11.8.4 Medpace Revenue in Decentralized & Digitalized Clinical Trials Business (2021–2026)
11.8.5 Medpace Recent Development
11.9 Patheon
11.9.1 Patheon Company Details
11.9.2 Patheon Business Overview
11.9.3 Patheon Decentralized & Digitalized Clinical Trials Introduction
11.9.4 Patheon Revenue in Decentralized & Digitalized Clinical Trials Business (2021–2026)
11.9.5 Patheon Recent Development
11.10 Signant Health
11.10.1 Signant Health Company Details
11.10.2 Signant Health Business Overview
11.10.3 Signant Health Decentralized & Digitalized Clinical Trials Introduction
11.10.4 Signant Health Revenue in Decentralized & Digitalized Clinical Trials Business (2021–2026)
11.10.5 Signant Health Recent Development
11.11 Syneos Health
11.11.1 Syneos Health Company Details
11.11.2 Syneos Health Business Overview
11.11.3 Syneos Health Decentralized & Digitalized Clinical Trials Introduction
11.11.4 Syneos Health Revenue in Decentralized & Digitalized Clinical Trials Business (2021–2026)
11.11.5 Syneos Health Recent Development
11.12 CRF Health
11.12.1 CRF Health Company Details
11.12.2 CRF Health Business Overview
11.12.3 CRF Health Decentralized & Digitalized Clinical Trials Introduction
11.12.4 CRF Health Revenue in Decentralized & Digitalized Clinical Trials Business (2021–2026)
11.12.5 CRF Health Recent Development
11.13 Clinical Ink
11.13.1 Clinical Ink Company Details
11.13.2 Clinical Ink Business Overview
11.13.3 Clinical Ink Decentralized & Digitalized Clinical Trials Introduction
11.13.4 Clinical Ink Revenue in Decentralized & Digitalized Clinical Trials Business (2021–2026)
11.13.5 Clinical Ink Recent Development
11.14 Medable
11.14.1 Medable Company Details
11.14.2 Medable Business Overview
11.14.3 Medable Decentralized & Digitalized Clinical Trials Introduction
11.14.4 Medable Revenue in Decentralized & Digitalized Clinical Trials Business (2021–2026)
11.14.5 Medable Recent Development
11.15 Obvio Health
11.15.1 Obvio Health Company Details
11.15.2 Obvio Health Business Overview
11.15.3 Obvio Health Decentralized & Digitalized Clinical Trials Introduction
11.15.4 Obvio Health Revenue in Decentralized & Digitalized Clinical Trials Business (2021–2026)
11.15.5 Obvio Health Recent Development
11.16 Fortrea
11.16.1 Fortrea Company Details
11.16.2 Fortrea Business Overview
11.16.3 Fortrea Decentralized & Digitalized Clinical Trials Introduction
11.16.4 Fortrea Revenue in Decentralized & Digitalized Clinical Trials Business (2021–2026)
11.16.5 Fortrea Recent Development
11.17 ProPharma
11.17.1 ProPharma Company Details
11.17.2 ProPharma Business Overview
11.17.3 ProPharma Decentralized & Digitalized Clinical Trials Introduction
11.17.4 ProPharma Revenue in Decentralized & Digitalized Clinical Trials Business (2021–2026)
11.17.5 ProPharma Recent Development
11.18 Cloudbyz
11.18.1 Cloudbyz Company Details
11.18.2 Cloudbyz Business Overview
11.18.3 Cloudbyz Decentralized & Digitalized Clinical Trials Introduction
11.18.4 Cloudbyz Revenue in Decentralized & Digitalized Clinical Trials Business (2021–2026)
11.18.5 Cloudbyz Recent Development
11.19 Science 37
11.19.1 Science 37 Company Details
11.19.2 Science 37 Business Overview
11.19.3 Science 37 Decentralized & Digitalized Clinical Trials Introduction
11.19.4 Science 37 Revenue in Decentralized & Digitalized Clinical Trials Business (2021–2026)
11.19.5 Science 37 Recent Development
11.20 Advarra
11.20.1 Advarra Company Details
11.20.2 Advarra Business Overview
11.20.3 Advarra Decentralized & Digitalized Clinical Trials Introduction
11.20.4 Advarra Revenue in Decentralized & Digitalized Clinical Trials Business (2021–2026)
11.20.5 Advarra Recent Development
11.21 Medrio
11.21.1 Medrio Company Details
11.21.2 Medrio Business Overview
11.21.3 Medrio Decentralized & Digitalized Clinical Trials Introduction
11.21.4 Medrio Revenue in Decentralized & Digitalized Clinical Trials Business (2021–2026)
11.21.5 Medrio Recent Development
11.22 Tigermed
11.22.1 Tigermed Company Details
11.22.2 Tigermed Business Overview
11.22.3 Tigermed Decentralized & Digitalized Clinical Trials Introduction
11.22.4 Tigermed Revenue in Decentralized & Digitalized Clinical Trials Business (2021–2026)
11.22.5 Tigermed Recent Development
11.23 Zhejiang Taimei Medical Technology
11.23.1 Zhejiang Taimei Medical Technology Company Details
11.23.2 Zhejiang Taimei Medical Technology Business Overview
11.23.3 Zhejiang Taimei Medical Technology Decentralized & Digitalized Clinical Trials Introduction
11.23.4 Zhejiang Taimei Medical Technology Revenue in Decentralized & Digitalized Clinical Trials Business (2021–2026)
11.23.5 Zhejiang Taimei Medical Technology Recent Development
11.24 Shanghai Yaocheng Health Technology
11.24.1 Shanghai Yaocheng Health Technology Company Details
11.24.2 Shanghai Yaocheng Health Technology Business Overview
11.24.3 Shanghai Yaocheng Health Technology Decentralized & Digitalized Clinical Trials Introduction
11.24.4 Shanghai Yaocheng Health Technology Revenue in Decentralized & Digitalized Clinical Trials Business (2021–2026)
11.24.5 Shanghai Yaocheng Health Technology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Decentralized & Digitalized Clinical Trials Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of Web-based
 Table 3. Key Players of Cloud-based
 Table 4. Global Decentralized & Digitalized Clinical Trials Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 5. Global Decentralized & Digitalized Clinical Trials Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 6. Global Decentralized & Digitalized Clinical Trials Market Size by Region (US$ Million), 2021–2026
 Table 7. Global Decentralized & Digitalized Clinical Trials Market Share by Region (2021–2026)
 Table 8. Global Decentralized & Digitalized Clinical Trials Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 9. Global Decentralized & Digitalized Clinical Trials Market Share by Region (2027–2032)
 Table 10. Decentralized & Digitalized Clinical Trials Market Trends
 Table 11. Decentralized & Digitalized Clinical Trials Market Drivers
 Table 12. Decentralized & Digitalized Clinical Trials Market Challenges
 Table 13. Decentralized & Digitalized Clinical Trials Market Restraints
 Table 14. Global Decentralized & Digitalized Clinical Trials Revenue by Players (US$ Million), 2021–2026
 Table 15. Global Decentralized & Digitalized Clinical Trials Market Share by Players (2021–2026)
 Table 16. Global Top Decentralized & Digitalized Clinical Trials Players by Tier (Tier 1, Tier 2, and Tier 3), based on Decentralized & Digitalized Clinical Trials Revenue, 2025
 Table 17. Ranking of Global Top Decentralized & Digitalized Clinical Trials Companies by Revenue (US$ Million) in 2025
 Table 18. Global 5 Largest Players Market Share by Decentralized & Digitalized Clinical Trials Revenue (CR5 and HHI), 2021–2026
 Table 19. Global Key Players of Decentralized & Digitalized Clinical Trials, Headquarters and Area Served
 Table 20. Global Key Players of Decentralized & Digitalized Clinical Trials, Products and Applications
 Table 21. Global Key Players of Decentralized & Digitalized Clinical Trials, Date of General Availability (GA)
 Table 22. Mergers and Acquisitions, Expansion Plans
 Table 23. Global Decentralized & Digitalized Clinical Trials Market Size by Type (US$ Million), 2021–2026
 Table 24. Global Decentralized & Digitalized Clinical Trials Revenue Market Share by Type (2021–2026)
 Table 25. Global Decentralized & Digitalized Clinical Trials Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 26. Global Decentralized & Digitalized Clinical Trials Revenue Market Share by Type (2027–2032)
 Table 27. Global Decentralized & Digitalized Clinical Trials Market Size by Application (US$ Million), 2021–2026
 Table 28. Global Decentralized & Digitalized Clinical Trials Revenue Market Share by Application (2021–2026)
 Table 29. Global Decentralized & Digitalized Clinical Trials Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 30. Global Decentralized & Digitalized Clinical Trials Revenue Market Share by Application (2027–2032)
 Table 31. North America Decentralized & Digitalized Clinical Trials Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 32. North America Decentralized & Digitalized Clinical Trials Market Size by Country (US$ Million), 2021–2026
 Table 33. North America Decentralized & Digitalized Clinical Trials Market Size by Country (US$ Million), 2027–2032
 Table 34. Europe Decentralized & Digitalized Clinical Trials Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 35. Europe Decentralized & Digitalized Clinical Trials Market Size by Country (US$ Million), 2021–2026
 Table 36. Europe Decentralized & Digitalized Clinical Trials Market Size by Country (US$ Million), 2027–2032
 Table 37. Asia-Pacific Decentralized & Digitalized Clinical Trials Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 38. Asia-Pacific Decentralized & Digitalized Clinical Trials Market Size by Region (US$ Million), 2021–2026
 Table 39. Asia-Pacific Decentralized & Digitalized Clinical Trials Market Size by Region (US$ Million), 2027–2032
 Table 40. Latin America Decentralized & Digitalized Clinical Trials Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 41. Latin America Decentralized & Digitalized Clinical Trials Market Size by Country (US$ Million), 2021–2026
 Table 42. Latin America Decentralized & Digitalized Clinical Trials Market Size by Country (US$ Million), 2027–2032
 Table 43. Middle East & Africa Decentralized & Digitalized Clinical Trials Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 44. Middle East & Africa Decentralized & Digitalized Clinical Trials Market Size by Country (US$ Million), 2021–2026
 Table 45. Middle East & Africa Decentralized & Digitalized Clinical Trials Market Size by Country (US$ Million), 2027–2032
 Table 46. Medidata Company Details
 Table 47. Medidata Business Overview
 Table 48. Medidata Decentralized & Digitalized Clinical Trials Product
 Table 49. Medidata Revenue in Decentralized & Digitalized Clinical Trials Business (US$ Million), 2021–2026
 Table 50. Medidata Recent Development
 Table 51. IQVIA Company Details
 Table 52. IQVIA Business Overview
 Table 53. IQVIA Decentralized & Digitalized Clinical Trials Product
 Table 54. IQVIA Revenue in Decentralized & Digitalized Clinical Trials Business (US$ Million), 2021–2026
 Table 55. IQVIA Recent Development
 Table 56. Labcorp Company Details
 Table 57. Labcorp Business Overview
 Table 58. Labcorp Decentralized & Digitalized Clinical Trials Product
 Table 59. Labcorp Revenue in Decentralized & Digitalized Clinical Trials Business (US$ Million), 2021–2026
 Table 60. Labcorp Recent Development
 Table 61. PRA Health Sciences Company Details
 Table 62. PRA Health Sciences Business Overview
 Table 63. PRA Health Sciences Decentralized & Digitalized Clinical Trials Product
 Table 64. PRA Health Sciences Revenue in Decentralized & Digitalized Clinical Trials Business (US$ Million), 2021–2026
 Table 65. PRA Health Sciences Recent Development
 Table 66. Parexel Company Details
 Table 67. Parexel Business Overview
 Table 68. Parexel Decentralized & Digitalized Clinical Trials Product
 Table 69. Parexel Revenue in Decentralized & Digitalized Clinical Trials Business (US$ Million), 2021–2026
 Table 70. Parexel Recent Development
 Table 71. ICON Company Details
 Table 72. ICON Business Overview
 Table 73. ICON Decentralized & Digitalized Clinical Trials Product
 Table 74. ICON Revenue in Decentralized & Digitalized Clinical Trials Business (US$ Million), 2021–2026
 Table 75. ICON Recent Development
 Table 76. Oracle Company Details
 Table 77. Oracle Business Overview
 Table 78. Oracle Decentralized & Digitalized Clinical Trials Product
 Table 79. Oracle Revenue in Decentralized & Digitalized Clinical Trials Business (US$ Million), 2021–2026
 Table 80. Oracle Recent Development
 Table 81. Medpace Company Details
 Table 82. Medpace Business Overview
 Table 83. Medpace Decentralized & Digitalized Clinical Trials Product
 Table 84. Medpace Revenue in Decentralized & Digitalized Clinical Trials Business (US$ Million), 2021–2026
 Table 85. Medpace Recent Development
 Table 86. Patheon Company Details
 Table 87. Patheon Business Overview
 Table 88. Patheon Decentralized & Digitalized Clinical Trials Product
 Table 89. Patheon Revenue in Decentralized & Digitalized Clinical Trials Business (US$ Million), 2021–2026
 Table 90. Patheon Recent Development
 Table 91. Signant Health Company Details
 Table 92. Signant Health Business Overview
 Table 93. Signant Health Decentralized & Digitalized Clinical Trials Product
 Table 94. Signant Health Revenue in Decentralized & Digitalized Clinical Trials Business (US$ Million), 2021–2026
 Table 95. Signant Health Recent Development
 Table 96. Syneos Health Company Details
 Table 97. Syneos Health Business Overview
 Table 98. Syneos Health Decentralized & Digitalized Clinical Trials Product
 Table 99. Syneos Health Revenue in Decentralized & Digitalized Clinical Trials Business (US$ Million), 2021–2026
 Table 100. Syneos Health Recent Development
 Table 101. CRF Health Company Details
 Table 102. CRF Health Business Overview
 Table 103. CRF Health Decentralized & Digitalized Clinical Trials Product
 Table 104. CRF Health Revenue in Decentralized & Digitalized Clinical Trials Business (US$ Million), 2021–2026
 Table 105. CRF Health Recent Development
 Table 106. Clinical Ink Company Details
 Table 107. Clinical Ink Business Overview
 Table 108. Clinical Ink Decentralized & Digitalized Clinical Trials Product
 Table 109. Clinical Ink Revenue in Decentralized & Digitalized Clinical Trials Business (US$ Million), 2021–2026
 Table 110. Clinical Ink Recent Development
 Table 111. Medable Company Details
 Table 112. Medable Business Overview
 Table 113. Medable Decentralized & Digitalized Clinical Trials Product
 Table 114. Medable Revenue in Decentralized & Digitalized Clinical Trials Business (US$ Million), 2021–2026
 Table 115. Medable Recent Development
 Table 116. Obvio Health Company Details
 Table 117. Obvio Health Business Overview
 Table 118. Obvio Health Decentralized & Digitalized Clinical Trials Product
 Table 119. Obvio Health Revenue in Decentralized & Digitalized Clinical Trials Business (US$ Million), 2021–2026
 Table 120. Obvio Health Recent Development
 Table 121. Fortrea Company Details
 Table 122. Fortrea Business Overview
 Table 123. Fortrea Decentralized & Digitalized Clinical Trials Product
 Table 124. Fortrea Revenue in Decentralized & Digitalized Clinical Trials Business (US$ Million), 2021–2026
 Table 125. Fortrea Recent Development
 Table 126. ProPharma Company Details
 Table 127. ProPharma Business Overview
 Table 128. ProPharma Decentralized & Digitalized Clinical Trials Product
 Table 129. ProPharma Revenue in Decentralized & Digitalized Clinical Trials Business (US$ Million), 2021–2026
 Table 130. ProPharma Recent Development
 Table 131. Cloudbyz Company Details
 Table 132. Cloudbyz Business Overview
 Table 133. Cloudbyz Decentralized & Digitalized Clinical Trials Product
 Table 134. Cloudbyz Revenue in Decentralized & Digitalized Clinical Trials Business (US$ Million), 2021–2026
 Table 135. Cloudbyz Recent Development
 Table 136. Science 37 Company Details
 Table 137. Science 37 Business Overview
 Table 138. Science 37 Decentralized & Digitalized Clinical Trials Product
 Table 139. Science 37 Revenue in Decentralized & Digitalized Clinical Trials Business (US$ Million), 2021–2026
 Table 140. Science 37 Recent Development
 Table 141. Advarra Company Details
 Table 142. Advarra Business Overview
 Table 143. Advarra Decentralized & Digitalized Clinical Trials Product
 Table 144. Advarra Revenue in Decentralized & Digitalized Clinical Trials Business (US$ Million), 2021–2026
 Table 145. Advarra Recent Development
 Table 146. Medrio Company Details
 Table 147. Medrio Business Overview
 Table 148. Medrio Decentralized & Digitalized Clinical Trials Product
 Table 149. Medrio Revenue in Decentralized & Digitalized Clinical Trials Business (US$ Million), 2021–2026
 Table 150. Medrio Recent Development
 Table 151. Tigermed Company Details
 Table 152. Tigermed Business Overview
 Table 153. Tigermed Decentralized & Digitalized Clinical Trials Product
 Table 154. Tigermed Revenue in Decentralized & Digitalized Clinical Trials Business (US$ Million), 2021–2026
 Table 155. Tigermed Recent Development
 Table 156. Zhejiang Taimei Medical Technology Company Details
 Table 157. Zhejiang Taimei Medical Technology Business Overview
 Table 158. Zhejiang Taimei Medical Technology Decentralized & Digitalized Clinical Trials Product
 Table 159. Zhejiang Taimei Medical Technology Revenue in Decentralized & Digitalized Clinical Trials Business (US$ Million), 2021–2026
 Table 160. Zhejiang Taimei Medical Technology Recent Development
 Table 161. Shanghai Yaocheng Health Technology Company Details
 Table 162. Shanghai Yaocheng Health Technology Business Overview
 Table 163. Shanghai Yaocheng Health Technology Decentralized & Digitalized Clinical Trials Product
 Table 164. Shanghai Yaocheng Health Technology Revenue in Decentralized & Digitalized Clinical Trials Business (US$ Million), 2021–2026
 Table 165. Shanghai Yaocheng Health Technology Recent Development
 Table 166. Research Programs/Design for This Report
 Table 167. Key Data Information from Secondary Sources
 Table 168. Key Data Information from Primary Sources
 Table 169. Authors List of This Report


List of Figures
 Figure 1. Decentralized & Digitalized Clinical Trials Picture
 Figure 2. Global Decentralized & Digitalized Clinical Trials Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global Decentralized & Digitalized Clinical Trials Market Share by Type: 2025 vs 2032
 Figure 4. Web-based Features
 Figure 5. Cloud-based Features
 Figure 6. Global Decentralized & Digitalized Clinical Trials Market Size by Application (US$ Million), 2021–2032
 Figure 7. Global Decentralized & Digitalized Clinical Trials Market Share by Application: 2025 vs 2032
 Figure 8. Oncology Case Studies
 Figure 9. Cardiovascular Case Studies
 Figure 10. Others Case Studies
 Figure 11. Decentralized & Digitalized Clinical Trials Report Years Considered
 Figure 12. Global Decentralized & Digitalized Clinical Trials Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 13. Global Decentralized & Digitalized Clinical Trials Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 14. Global Decentralized & Digitalized Clinical Trials Market Share by Region: 2025 vs 2032
 Figure 15. Global Decentralized & Digitalized Clinical Trials Market Share by Players in 2025
 Figure 16. Global Decentralized & Digitalized Clinical Trials Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 17. The Top 10 and 5 Players Market Share by Decentralized & Digitalized Clinical Trials Revenue in 2025
 Figure 18. North America Decentralized & Digitalized Clinical Trials Market Size YoY Growth (US$ Million), 2021–2032
 Figure 19. North America Decentralized & Digitalized Clinical Trials Market Share by Country (2021–2032)
 Figure 20. United States Decentralized & Digitalized Clinical Trials Market Size YoY Growth (US$ Million), 2021–2032
 Figure 21. Canada Decentralized & Digitalized Clinical Trials Market Size YoY Growth (US$ Million), 2021–2032
 Figure 22. Europe Decentralized & Digitalized Clinical Trials Market Size YoY Growth (US$ Million), 2021–2032
 Figure 23. Europe Decentralized & Digitalized Clinical Trials Market Share by Country (2021–2032)
 Figure 24. Germany Decentralized & Digitalized Clinical Trials Market Size YoY Growth (US$ Million), 2021–2032
 Figure 25. France Decentralized & Digitalized Clinical Trials Market Size YoY Growth (US$ Million), 2021–2032
 Figure 26. U.K. Decentralized & Digitalized Clinical Trials Market Size YoY Growth (US$ Million), 2021–2032
 Figure 27. Italy Decentralized & Digitalized Clinical Trials Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. Russia Decentralized & Digitalized Clinical Trials Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. Ireland Decentralized & Digitalized Clinical Trials Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. Asia-Pacific Decentralized & Digitalized Clinical Trials Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. Asia-Pacific Decentralized & Digitalized Clinical Trials Market Share by Region (2021–2032)
 Figure 32. China Decentralized & Digitalized Clinical Trials Market Size YoY Growth (US$ Million), 2021–2032
 Figure 33. Japan Decentralized & Digitalized Clinical Trials Market Size YoY Growth (US$ Million), 2021–2032
 Figure 34. South Korea Decentralized & Digitalized Clinical Trials Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. Southeast Asia Decentralized & Digitalized Clinical Trials Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. India Decentralized & Digitalized Clinical Trials Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. Australia & New Zealand Decentralized & Digitalized Clinical Trials Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. Latin America Decentralized & Digitalized Clinical Trials Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. Latin America Decentralized & Digitalized Clinical Trials Market Share by Country (2021–2032)
 Figure 40. Mexico Decentralized & Digitalized Clinical Trials Market Size YoY Growth (US$ Million), 2021–2032
 Figure 41. Brazil Decentralized & Digitalized Clinical Trials Market Size YoY Growth (US$ Million), 2021–2032
 Figure 42. Middle East & Africa Decentralized & Digitalized Clinical Trials Market Size YoY Growth (US$ Million), 2021–2032
 Figure 43. Middle East & Africa Decentralized & Digitalized Clinical Trials Market Share by Country (2021–2032)
 Figure 44. Israel Decentralized & Digitalized Clinical Trials Market Size YoY Growth (US$ Million), 2021–2032
 Figure 45. Saudi Arabia Decentralized & Digitalized Clinical Trials Market Size YoY Growth (US$ Million), 2021–2032
 Figure 46. UAE Decentralized & Digitalized Clinical Trials Market Size YoY Growth (US$ Million), 2021–2032
 Figure 47. Medidata Revenue Growth Rate in Decentralized & Digitalized Clinical Trials Business (2021–2026)
 Figure 48. IQVIA Revenue Growth Rate in Decentralized & Digitalized Clinical Trials Business (2021–2026)
 Figure 49. Labcorp Revenue Growth Rate in Decentralized & Digitalized Clinical Trials Business (2021–2026)
 Figure 50. PRA Health Sciences Revenue Growth Rate in Decentralized & Digitalized Clinical Trials Business (2021–2026)
 Figure 51. Parexel Revenue Growth Rate in Decentralized & Digitalized Clinical Trials Business (2021–2026)
 Figure 52. ICON Revenue Growth Rate in Decentralized & Digitalized Clinical Trials Business (2021–2026)
 Figure 53. Oracle Revenue Growth Rate in Decentralized & Digitalized Clinical Trials Business (2021–2026)
 Figure 54. Medpace Revenue Growth Rate in Decentralized & Digitalized Clinical Trials Business (2021–2026)
 Figure 55. Patheon Revenue Growth Rate in Decentralized & Digitalized Clinical Trials Business (2021–2026)
 Figure 56. Signant Health Revenue Growth Rate in Decentralized & Digitalized Clinical Trials Business (2021–2026)
 Figure 57. Syneos Health Revenue Growth Rate in Decentralized & Digitalized Clinical Trials Business (2021–2026)
 Figure 58. CRF Health Revenue Growth Rate in Decentralized & Digitalized Clinical Trials Business (2021–2026)
 Figure 59. Clinical Ink Revenue Growth Rate in Decentralized & Digitalized Clinical Trials Business (2021–2026)
 Figure 60. Medable Revenue Growth Rate in Decentralized & Digitalized Clinical Trials Business (2021–2026)
 Figure 61. Obvio Health Revenue Growth Rate in Decentralized & Digitalized Clinical Trials Business (2021–2026)
 Figure 62. Fortrea Revenue Growth Rate in Decentralized & Digitalized Clinical Trials Business (2021–2026)
 Figure 63. ProPharma Revenue Growth Rate in Decentralized & Digitalized Clinical Trials Business (2021–2026)
 Figure 64. Cloudbyz Revenue Growth Rate in Decentralized & Digitalized Clinical Trials Business (2021–2026)
 Figure 65. Science 37 Revenue Growth Rate in Decentralized & Digitalized Clinical Trials Business (2021–2026)
 Figure 66. Advarra Revenue Growth Rate in Decentralized & Digitalized Clinical Trials Business (2021–2026)
 Figure 67. Medrio Revenue Growth Rate in Decentralized & Digitalized Clinical Trials Business (2021–2026)
 Figure 68. Tigermed Revenue Growth Rate in Decentralized & Digitalized Clinical Trials Business (2021–2026)
 Figure 69. Zhejiang Taimei Medical Technology Revenue Growth Rate in Decentralized & Digitalized Clinical Trials Business (2021–2026)
 Figure 70. Shanghai Yaocheng Health Technology Revenue Growth Rate in Decentralized & Digitalized Clinical Trials Business (2021–2026)
 Figure 71. Bottom-up and Top-down Approaches for This Report
 Figure 72. Data Triangulation
 Figure 73. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona